Lawsuit: Arca Biopharma investor cries foul on merger proposal
WESTMINSTER — A shareholder of Westminster-based drug developer Arca Biopharma Inc. (Nasdaq: ABIO) is asking a judge to block the company’s attempt to merge with Oruka Therapeutics Inc., a private dermatology-centered biotechnology firm headquartered in …